Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Schedule of Available-for-Sale Marketable Securities

The following is a summary of available-for-sale marketable securities, as of December 31, 2024 and 2023, respectively (in thousands):

	December 31, 2024
	Amortized Cost		Unrealized Gain		Unrealized Losses		Fair Value
Marketable securities:
Corporate securities (1)	$	43,008	$	9	$	(74)	$	42,943
U.S. treasury and agency securities	3,097		—		(4)		3,093
Total marketable securities	$	46,105	$	9	$	(78)	$	46,036

(1)Comprised primarily of corporate bonds

	December 31, 2023
	Amortized Cost		Unrealized Gain		Unrealized Losses		Fair Value
Cash equivalents:
Corporate securities (1)	$	1,213	$	—	$	(1)	$	1,212
Total cash equivalents	1,213		—		(1)		1,212
Marketable securities:
Corporate securities (1)	$	199,084	$	115	$	(819)	$	198,380
U.S. treasury and agency securities	30,404		25		(48)		30,381
Total marketable securities	$	229,488	$	140	$	(867)	$	228,761

(1)Comprised primarily of corporate bonds and commercial paper

Schedule of Fair Values of Available-for-Sale Marketable Securities

As of December 31, 2024, the fair values of available-for-sale financial instruments, by remaining contractual maturity, were as follows (in thousands):

Due within one year	$	30,782
Due in one to five years	15,254
Total	$	46,036